| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/01/2011 | US20110212476 Genetically engineered g-alpha proteins and uses thereof |
| 09/01/2011 | US20110212470 Biomarkers for rheumatoid arthritis |
| 09/01/2011 | US20110212459 Novel presenilin associated membrane protein (pamp) and uses thereof |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212223 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 09/01/2011 | US20110212177 Configurable microscopic medical payload delivery device to deliver medically therapeutic payloads to specifically targeted cell types |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/01/2011 | US20110212160 Configurable microscopic medical payload delivery device to deliver nuclear signaling proteins to specific cells to manage diabetes mellitus and genetic deficiency disorders |
| 09/01/2011 | US20110212134 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212125 Vaccine for shigella |
| 09/01/2011 | US20110212122 Nerve Growth Factor Conjugates and Uses Thereof |
| 09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
| 09/01/2011 | US20110212116 Immunogenic peptides and uses thereof |
| 09/01/2011 | US20110212108 Neuregulin/erbb signaling and integrin |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212088 Anti-paf antibodies |
| 09/01/2011 | US20110212085 Lung cancer disease targets and uses thereof |
| 09/01/2011 | US20110212083 Role of soluble upar in the pathogenesis of proteinuric kidney disease |
| 09/01/2011 | US20110212059 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212030 Nucleic Acid Ligand Complexes |
| 09/01/2011 | US20110212028 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 09/01/2011 | US20110212024 Marker for inflammatory conditions |
| 09/01/2011 | CA2791787A1 Recombinant cdv compositions and uses thereof |
| 09/01/2011 | CA2791153A1 Immunogenic proteins and compositions |
| 09/01/2011 | CA2790984A1 Combination vaccine for streptococcus |
| 09/01/2011 | CA2790818A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | CA2790526A1 Clostridium gene |
| 09/01/2011 | CA2789060A1 Plants having enhanced yield-related traits and a method for making the same |
| 08/31/2011 | EP2361982A1 Human gene encoding ubiquitin conjugating enzyme |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361977A1 Nucleic acid sequences encoding proteins associated with abiotic stress response, and transgenic plant cells transformed with the same |
| 08/31/2011 | EP2361974A1 Use of proteins and peptides encoded by the genome of a new coronavirus strain associated with SARS |
| 08/31/2011 | EP2361932A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 08/31/2011 | EP2361930A2 Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| 08/31/2011 | EP2361929A1 Neoplasm-specific polypeptides and their use |
| 08/31/2011 | EP2361928A1 Truncated fragments of alpha-synuclein in Lewy body disease |
| 08/31/2011 | EP2361927A1 Plants having enhanced yield-related traits and a method for making the same |
| 08/31/2011 | EP2361926A2 Yersinia SSP. polypeptides and methods of use |
| 08/31/2011 | EP2361924A1 Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361634A1 Proteins/peptides having immunogenic properties and their biological applications |
| 08/31/2011 | EP2361633A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 08/31/2011 | EP2361307A1 Pesticidal genes from brevibacillus and methods for their use |
| 08/31/2011 | EP2361262A1 Tetranectin trimeri zing module truncation variants |
| 08/31/2011 | EP2361261A1 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases |
| 08/31/2011 | EP2361260A1 Novel transporter constructs and transporter cargo conjugate molecules |
| 08/31/2011 | EP2361259A1 Efficient transport into white blood cells |
| 08/31/2011 | EP2361097A2 Na/k-atpase-derived peptide src inhibitors and ouabain antagonists and uses thereof |
| 08/31/2011 | EP2361093A2 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| 08/31/2011 | EP2207795B1 Process for producing mature recombinant mite group i allergen |
| 08/31/2011 | EP2054431B1 Conformers of bacterial adhesins |
| 08/31/2011 | EP2041169B1 Amidated glargine insulin |
| 08/31/2011 | EP1694703B1 Process for purifying interferon beta |
| 08/31/2011 | EP1659919B1 Hemostatic devices containing a protein precipitate |
| 08/31/2011 | EP1625163B1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-43 |
| 08/31/2011 | EP1530629B1 Variants of antithrombin iii |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1446422B1 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |
| 08/31/2011 | EP1334185B1 Method for producing proteins by electroporation |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | EP1071711B1 Process for the recovery and purification of a recombinant protein from a cell |
| 08/31/2011 | CN1833024B Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto |
| 08/31/2011 | CN102171344A Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism |
| 08/31/2011 | CN102171343A FGFR extracellular domain acidic region muteins |
| 08/31/2011 | CN102171334A Method for producing purified influenza virus antigen |
| 08/31/2011 | CN102171247A TNF-alpha antagonist multi-target binding proteins |
| 08/31/2011 | CN102171246A Novel octapeptide compounds derived from somatostatin and therapeutic use thereof |
| 08/31/2011 | CN102171245A Halogen-stabilized insulin |
| 08/31/2011 | CN102171244A Analogues of glucose-dependent insulinotropic polypeptide |
| 08/31/2011 | CN102171243A Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal |
| 08/31/2011 | CN102171242A G6PC2-encoded beta cell surface tags |
| 08/31/2011 | CN102171241A Epitopes derived from SATB2 and uses thereof |
| 08/31/2011 | CN102171240A Methods of treating inflammation |
| 08/31/2011 | CN102171239A Peptides and compositions for prevention of cell adhesion and methods of using same |
| 08/31/2011 | CN102171186A Treatment or prevention of hepatitis c with immunomodulator compounds |
| 08/31/2011 | CN102170897A Vaccine containing amb a 1 for treating allergy to ragweed |
| 08/31/2011 | CN102168095A Expression and application of recombinant bacilysin |
| 08/31/2011 | CN102168094A Kandelia candel (L.) druce ERF (ethylene-responsive element binding factor) transcription factor as well as encoding gene, expression vector and application thereof |
| 08/31/2011 | CN102168093A Antibacterial peptide gene from wild rhizoma gastrodiae |
| 08/31/2011 | CN102168092A HsCIPK2 gene of Hordeum spontoneum C. Koch on Tibetan Plateau |
| 08/31/2011 | CN102168091A Qinghai-Tibet Plateau wild barley HsCIPK5 gene |
| 08/31/2011 | CN102168090A HsCIPK26 gene of Qinghai-Tibet Plateau wild barley |
| 08/31/2011 | CN102168089A Echinococcus granulosus calreticulin gene and application thereof |
| 08/31/2011 | CN102168088A T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine |
| 08/31/2011 | CN102168083A Method for culturing transgenic plant with decreased wax |
| 08/31/2011 | CN102167739A Method for purifying human urinary trypsin inhibitor by utilizing salt resistant mixed mode adsorbent |
| 08/31/2011 | CN102167738A Method for separating and purifying thymosin beta4 |
| 08/31/2011 | CN102167737A Swine immune trait related protein and encoding gene as well as application thereof |
| 08/31/2011 | CN102167736A Green mud crab antibacterial peptide Sphistin and application thereof |
| 08/31/2011 | CN102167735A Recombinant antigen protein of S.japonicum SjTollip and preparation method and application thereof |
| 08/31/2011 | CN102167734A High-efficiency expression and application of recombinant mutant tenebrio molitor antibacterial peptide |
| 08/31/2011 | CN102167733A Construction, expression and application of acidly cleavable high-copy antihypertensive peptide tandem gene |
| 08/31/2011 | CN102167732A Protein type algicidal compound and preparation method thereof |
| 08/31/2011 | CN102166354A Rabies inactivated vaccine and preparation method thereof |
| 08/31/2011 | CN101624613B Bio-modification preparation method for improving activity of laver phycoerythrin |